Venture Capital Associate

Investinequity; City Of London; On-site; GBP 60,000 - 80,000; Full time

Job summary

A venture fund focused on neuroscience is seeking a detail-oriented Associate to join their investment team. This role will involve leading due diligence efforts, translating scientific insights into investment recommendations, and supporting deal structuring. Ideal candidates will hold an advanced degree in a relevant field and have experience in biotech strategy or investment consulting. Join a mission-driven firm shaping the future of therapeutic innovation with opportunities for growth and leadership.

Benefits

Ownership of meaningful workstreams

Clear path towards leadership

Supportive team environment

Qualifications

• Advanced degree in relevant field such as neuroscience.
• Experience in biotech/pharma strategy or investment consulting.
• Interest in venture capital and innovation in healthcare.

Responsibilities

• Lead due diligence efforts in scientific and regulatory areas.
• Translate insights into investment recommendations.
• Support deal structuring and negotiation.
• Build relationships with founders and investors.

Skills

Scientific due diligence

Investment analysis

Biotech strategy

Collaboration

Communication

Education

PhD, MD, or equivalent in neuroscience, bioengineering, pharmacology, immunology, molecular biology

Job description

• SCI Ventures is the first venture fund focused on advancing new treatments for paralysis, investing globally in neuroscience and regenerative medicine breakthroughs.
• We view spinal cord injury (SCI) as a gateway to broader neurological innovation - spanning Stroke, Alzheimer's, Parkinson's, ALS, MS, and beyond.
• Backed by leading medical foundations across the US, UK, and EU, we are actively engaged across the full life cycle - from funding early-stage innovators to co-developing new therapeutic programs within established biotech companies.
• Onward Medical, which developed the first brain-computer interface (BCI) enabling a person with paralysis to walk using their thoughts;
• Axonis Therapeutics, whose neuromodulating drug for SCI, epilepsy, and pain is entering clinical trials following a $115M Series A.

With multiple companies moving into the clinic, we are accelerating the future of neuroregeneration - bringing forward new possibilities, and hope, to millions.

Role Overview

• We are looking for a curious, collaborative, and detail-oriented Associate to join our investment team as one of the founding members of a newly formed early-stage VC.
• You will have the opportunity to build meaningful relationships with founders, support due diligence processes, and grow into independently leading investment opportunities.
• We welcome applicants with a strong background in life sciences and experience in biotech/pharma strategy, due diligence, or investment advisory.

Key Responsibilities

• Contribute to and help lead due diligence efforts - across scientific, clinical, regulatory, and commercial areas;
• Translate complex scientific and market insights into clear investment recommendations for the Investment Committee;
• Support deal structuring, negotiation, and ongoing portfolio company engagement;
• Participate in industry events, scientific conferences, and ecosystem networking;
• Build and nurture relationships with founders, scientific leaders, and fellow investors.

Qualifications & Skills

• Advanced degree (PhD, MD, or equivalent) in a relevant field such as neuroscience, bioengineering, pharmacology, immunology, molecular biology, or a related discipline;
• Experience in biotech/pharma strategy, due diligence, or investment consulting;
• Interest in venture capital, entrepreneurship, and advancing innovation in healthcare;
• Experience collaborating with startups or early-stage teams is a plus.

Why Join Us?

• Be part of a mission-driven firm shaping the future of neuroscience and therapeutic innovation;
• Join a supportive, close-knit team with strong scientific, entrepreneurial, and investment experience;
• Take ownership of meaningful workstreams with the opportunity to grow into leading your own investment deals;
• Access a clear path toward expanded leadership in a growing and purpose-led firm.

TRANSFORM GENDER EQUITY IN LIFE SCIENCE INVESTment